Back

Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial

20 May 2023 (15:00 - 15:35)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - pharmacotherapy Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jurgen Bogoviku

University hospital Jena, Jena (Germany)

5 More presentations in this session

Presentation thumbnail
Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis
Doctor D. Rodolico (Pisa, IT)
Abstract Slides
Presentation thumbnail
Effect of SGLT-2 inhibitors on weight loss in HFrEF and HFpEF patients: meta-analysis of 14 thousand participants
Doctor A. Sunjaya (Jakarta, ID)
Abstract Slides
Presentation thumbnail
Benzodiazepines in patients with acute heart failure: a propensity score matching study
Doctor P. Salamanca Bautista (Seville, ES)
Abstract Slides
Presentation thumbnail
Pharmacotherapy modifications in acute heart failure
Mr J. Stevancec (Murska Sobota, SI)
Abstract Slides
Presentation thumbnail
Hypertonic saline in the management of refractory congestion in decompensated heart failure
Doctor C. Saldarriaga (Medellin, CO)
Abstract Slides

Access the full session

Session thumbnail
Acute heart failure - pharmacotherapy

The Event

Event poster

Heart Failure 2023

20 May 2023 15:00 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources